University of Lausanne
Lausanne, Switzerland
Purpose
to develop optimized aluminium-based formulations of IPV vaccine to achieve dose-reduction with the ultimate goal of accelerating polio eradication and pursue safe vaccination during the post-eradication era.
Division
Global Health
Date
November 2012
Region Served
GLOBAL
Committed amount
$110,641
Grant topic
Discovery and Translational Sciences
Duration (months)
48
Grantee location
Lausanne, Switzerland
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.